ABBV

AbbVie

$215.40

+2.28 (+1.07%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 28.05.2026
$252.90
(+17.41%)
Strong Buy: 8
Buy: 16
Hold: 8
Sell: 0
Strong Sell: 0
Description:
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Exchange:
NYSE
Country:
USA
Sector:
HEALTHCARE
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, UNITED STATES, 60064-6400
Fiscal year end:
December
Market capitalization:
$377 Billion
EBITDA:
$29.9 Billion
PERatio:
103.96
EPS:
2.05
Dividend per share:
$6.74
Dividend yield:
3.12%
Beta:
0.305

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 13 years:
+929%
How much will you get:
$10,295
Prices dates:
02-01-2013: $20.53 and 30-04-2026: $211.32